Headache. migraine and other headache syndromes
Conditions
Interventions
Intervention 1: Intervention group 1: In this group, Midazolam (1cc, 5 mg, Darou pakhsh, Tehran, IR Iran) 0.02 mg/kg plus Apotel (1 gr, 6.7 cc, cobel darou, Tehran, IR Iran) 15 mg/kg (up to 1 gr) will
Treatment - Drugs
Intervention group 1: In this group, Midazolam (1cc, 5 mg, Darou pakhsh, Tehran, IR Iran) 0.02 mg/kg plus Apotel (1 gr, 6.7 cc, cobel darou, Tehran, IR Iran) 15 mg/kg (up to 1 gr) will be used intrave
Intervention group 2: In this group, Apotel (1 gr, 6.7 cc, cobel darou, Tehran, IR Iran) 15 mg/kg (up to 1 gr) will be used intravenously.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: All 18-65 years old patients with primary headache (Migraine or tension). Exclusion criteria: Sensitivity to used medicine, secondary type headache, vomiting, pregnancy, loss of consciousness, hepatic failure, breast-feeding, renal failure, psychotic disorder, get a medicine before arriving to emergency ward, dissatisfaction to participate to study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of pain relief. Timepoint: The time between medicine prescription and pain releif. Method of measurement: With stopwatch. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. Timepoint: After the end of treatment, we will ask from patient about satisfaction of treatment. Method of measurement: Visual Analog Scale. This scale contains 1-10 scores that score 1 shows dissatisfaction and score 10 show excellent satisfaction. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Rahmani
Tabriz University of Medical Sciences
Outcome results
None listed